Abattis Bioceuticals Corp. (ATTBF)

[GreenBrickRoad]

Abattis' Northern Vine Labs Receives Controlled Substance Licence

Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQB: ATTBF) (CSE: ATT), is pleased to announce that Northern Vine has received a letter from Health Canada and a copy of the licence informing that it is now an authorized Licensed Dealer.

"We wish to congratulate the Northern Vine team on this important milestone for the Company. We have remained patient in obtaining this licence. We persevered and were granted Licence No. 2016/6368 for our Northern Vine facility.

'The licence allows for the analytical testing of samples of cannabis received from holders of a valid licence issued under the Narcotic Control Regulations, the Access to Cannabis for Medical Purposes Regulators or from an individual authorized by a valid exemption under the Controlled Drugs and Substances Act to provide, deliver, transport or send fresh or dried marihuana or cannabis to licensed dealers for the purposes of analytical testing.'

. . . .

Read full PR at: http://www.nasdaq.com/press-release/abattis-northern-vine-labs-receives-controlled-substance-licence-20161003-00561